June 22, 2011
New York, NY-Venture Planning Group (www.VPGMarketResearch.com), an international publishing and management consulting firm, is pleased to add a new report to its collection of market research and technology assessments publications:
“The Global Nucleic Acid Testing Market” is a seven-country study designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade.
Report Highlights
– Business and technological trends in the US, Europe (France,
Germany, Italy, Spain, UK) and Japan.
– Five- and ten-year test volume and sales forecasts
– Market shares of leading competitors
– Feature comparison of major analyzers
– Profiles of market players and start-up firms developing innovative technologies
and products
– Specific product and business opportunities for instrument and consumable
suppliers.
“The Global Nucleic Acid Testing Market” is based on a combination of primary and secondary information sources, including interviews with laboratory directors and executives of leading diagnostics companies and start-up firms developing innovative technologies and product in the U.S., five major European countries and Japan.
After you have had a chance to review the Table of Contents, I would be glad to answer any questions you might have about this informative, comprehensive and insightful market research and technology assessment report.
Best regards,
Robert Fisher
Healthcare Research
[email protected]
+1 212 564 2838
VPGMarketResearch.com
